[ad_1]
Federal health agencies in the United States will pause their use of the Johnson & Johnson coronavirus vaccine and are urging states across the country to follow suit while they investigate cases of blood clots, a report has said.
According to The New York Times, the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC) will call on Tuesday for an immediate pause in the use of the single-dose shot.
The mover reportedly comes after six people who received the vaccine in the country developed a rare disorder involving blood clots within about two weeks of vaccination, the newspaper said, citing officials briefed on the decision.
The Times said that the six recipients were all women who fell between the ages of 18 and 48. One woman is reported to have died while another in Nebraska remains in critical condition, the newspaper said.
According to data from the CDC, just under seven million people have received a shot of the Johnson & Johnson vaccine so far, with over 16 million having been delivered to states across the country.
The federal government is expected to pause administration of the vaccine at all federally run vaccination sites and has reccomended health practitioners across the states to do the same.
While the country moves to pause the rollout of the shot, scientists with the two health bodies will investigate possible links between the vaccine and rare disorder, known as cerebral venous thrombosis.
[ad_2]
Source link
